Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	230.71	317.5	474.88	651.55	1,029	712.36
Short-Term Investments	738.13	591.22	658.47	696.8	366.3	871.2
Trading Asset Securities	-	-	18.66	17.77	19.65	20.71
Cash & Short-Term Investments	968.84	908.72	1,152	1,366	1,415	1,604
Cash Growth	6.07%	-21.12%	-15.67%	-3.43%	-11.82%	-1.48%
Accounts Receivable	144.08	175.16	138.92	130.52	149.05	102.34
Other Receivables	64.08	2.61	2.8	1.84	2.06	306.62
Receivables	208.17	177.77	141.71	132.36	151.11	408.97
Inventory	182.28	161.79	188.76	115.2	115.18	103.02
Prepaid Expenses	24.87	12.21	16.43	3.84	7.84	8.44
Other Current Assets	55.02	8.26	125.78	2.04	2.13	0.3
Total Current Assets	1,439	1,269	1,625	1,620	1,691	2,125
Property, Plant & Equipment	27.75	29.51	7.65	14.54	22.51	28.82
Long-Term Investments	338.26	418.6	119.7	134.74	93.33	77.48
Other Intangible Assets	0.5	0.6	0.79	0.05	0.25	2.91
Long-Term Accounts Receivable	14.72	17.1	-	1.99	6.68	11.25
Long-Term Deferred Tax Assets	10.27	10.41	7.77	6.71	10.07	8.76
Other Long-Term Assets	6.84	4.81	4.83	5.63	7.33	10.74
Total Assets	1,838	1,750	1,765	1,783	1,831	2,265
Accounts Payable	66.36	25.9	62.69	46.71	89.95	28.52
Accrued Expenses	55.81	81	96.88	80.1	95.23	51
Current Portion of Leases	9.97	9.81	5.05	10.08	9.83	9.39
Current Income Taxes Payable	57.98	56.41	80.35	40.51	40.15	121.39
Current Unearned Revenue	18.02	11.52	8.26	8.05	13.59	12.44
Other Current Liabilities	169.64	68.57	35.65	33.75	30.42	17.56
Total Current Liabilities	377.78	253.2	288.88	219.18	279.16	240.3
Long-Term Leases	31.93	36.96	-	5.6	15.68	24.59
Long-Term Deferred Tax Liabilities	-	3.3	0.98	28.18	-	-
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.26	1.49
Total Liabilities	410.97	294.71	291.12	254.22	296.1	266.37
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	241.8	241.8	331.89	421.99	512.08	692.27
Retained Earnings	734.26	762.78	691.96	548.78	479.09	778.38
Comprehensive Income & Other	-	-	-	107.77	93.31	77.45
Shareholders' Equity	1,427	1,455	1,474	1,529	1,535	1,999
Total Liabilities & Equity	1,838	1,750	1,765	1,783	1,831	2,265
Total Debt	41.9	46.77	5.05	15.68	25.5	33.98
Net Cash (Debt)	926.94	861.95	1,147	1,350	1,389	1,570
Net Cash Growth	7.55%	-24.85%	-15.07%	-2.78%	-11.54%	-0.94%
Net Cash Per Share	20.50	19.08	25.44	29.95	30.80	34.76
Filing Date Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.05	45.05	45.05	45.05	45.05	45.05
Working Capital	1,061	1,016	1,336	1,400	1,412	1,885
Book Value Per Share	31.67	32.30	32.73	33.94	34.07	44.37
Tangible Book Value	1,426	1,454	1,474	1,529	1,535	1,996
Tangible Book Value Per Share	31.66	32.29	32.71	33.94	34.07	44.30
Machinery	-	-	-	-	-	1
Leasehold Improvements	-	-	-	-	-	20.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.